These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
410 related articles for article (PubMed ID: 21750072)
1. Guillain-Barre syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccine: multinational case-control study in Europe. Dieleman J; Romio S; Johansen K; Weibel D; Bonhoeffer J; Sturkenboom M; BMJ; 2011 Jul; 343():d3908. PubMed ID: 21750072 [TBL] [Abstract][Full Text] [Related]
2. Guillain-Barré syndrome and adjuvanted pandemic influenza A (H1N1) 2009 vaccines: a multinational self-controlled case series in Europe. Romio S; Weibel D; Dieleman JP; Olberg HK; de Vries CS; Sammon C; Andrews N; Svanström H; Mølgaard-Nielsen D; Hviid A; Lapeyre-Mestre M; Sommet A; Saussier C; Castot A; Heijbel H; Arnheim-Dahlström L; Sparen P; Mosseveld M; Schuemie M; van der Maas N; Jacobs BC; Leino T; Kilpi T; Storsaeter J; Johansen K; Kramarz P; Bonhoeffer J; Sturkenboom MC PLoS One; 2014; 9(1):e82222. PubMed ID: 24404128 [TBL] [Abstract][Full Text] [Related]
3. Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm, Sweden. Bardage C; Persson I; Ortqvist A; Bergman U; Ludvigsson JF; Granath F BMJ; 2011 Oct; 343():d5956. PubMed ID: 21994316 [TBL] [Abstract][Full Text] [Related]
4. Risk of Guillain-Barré syndrome following pandemic influenza A(H1N1) 2009 vaccination in Germany. Prestel J; Volkers P; Mentzer D; Lehmann HC; Hartung HP; Keller-Stanislawski B; Pharmacoepidemiol Drug Saf; 2014 Nov; 23(11):1192-204. PubMed ID: 24817531 [TBL] [Abstract][Full Text] [Related]
5. Association between Guillain-Barré syndrome and influenza A (H1N1) 2009 monovalent inactivated vaccines in the USA: a meta-analysis. Salmon DA; Proschan M; Forshee R; Gargiullo P; Bleser W; Burwen DR; Cunningham F; Garman P; Greene SK; Lee GM; Vellozzi C; Yih WK; Gellin B; Lurie N; Lancet; 2013 Apr; 381(9876):1461-8. PubMed ID: 23498095 [TBL] [Abstract][Full Text] [Related]
6. Risk of Guillain-Barré syndrome following H1N1 influenza vaccination in Quebec. De Wals P; Deceuninck G; Toth E; Boulianne N; Brunet D; Boucher RM; Landry M; De Serres G JAMA; 2012 Jul; 308(2):175-81. PubMed ID: 22782419 [TBL] [Abstract][Full Text] [Related]
7. Guillain-Barré syndrome and H1N1 (2009) pandemic influenza vaccination using an AS03 adjuvanted vaccine in the United Kingdom: self-controlled case series. Andrews N; Stowe J; Al-Shahi Salman R; Miller E Vaccine; 2011 Oct; 29(45):7878-82. PubMed ID: 21875631 [TBL] [Abstract][Full Text] [Related]
8. Chart-confirmed guillain-barre syndrome after 2009 H1N1 influenza vaccination among the Medicare population, 2009-2010. Polakowski LL; Sandhu SK; Martin DB; Ball R; Macurdy TE; Franks RL; Gibbs JM; Kropp GF; Avagyan A; Kelman JA; Worrall CM; Sun G; Kliman RE; Burwen DR Am J Epidemiol; 2013 Sep; 178(6):962-73. PubMed ID: 23652165 [TBL] [Abstract][Full Text] [Related]
9. Passive surveillance of adverse events of an MF59-adjuvanted H1N1v vaccine during the pandemic mass vaccinations. Banzhoff A; Haertel S; Praus M Hum Vaccin; 2011 May; 7(5):539-48. PubMed ID: 21422814 [TBL] [Abstract][Full Text] [Related]
10. Events supposedly attributable to vaccination or immunization during pandemic influenza A (H1N1) vaccination campaigns in Latin America and the Caribbean. Ropero-Álvarez AM; Whittembury A; Bravo-Alcántara P; Kurtis HJ; Danovaro-Holliday MC; Velandia-González M Vaccine; 2015 Jan; 33(1):187-92. PubMed ID: 25444798 [TBL] [Abstract][Full Text] [Related]
12. Pandemic A/H1N1 2009 influenza vaccination, preceding infections and clinical findings in UK children with Guillain-Barré syndrome. Verity C; Stellitano L; Winstone AM; Stowe J; Andrews N; Miller E Arch Dis Child; 2014 Jun; 99(6):532-8. PubMed ID: 24585755 [TBL] [Abstract][Full Text] [Related]
13. Guillain-Barré syndrome following pandemic (H1N1) 2009 influenza A immunisation in Victoria: a self-controlled case series. Crawford NW; Cheng A; Andrews N; Charles PG; Clothier HJ; Day B; Day T; Gates P; Macdonell R; Roberts L; Rodriguez-Casero V; Wijeratne T; Kiers L Med J Aust; 2012 Nov; 197(10):574-8. PubMed ID: 23163689 [TBL] [Abstract][Full Text] [Related]
14. Preliminary results: surveillance for Guillain-Barré syndrome after receipt of influenza A (H1N1) 2009 monovalent vaccine - United States, 2009-2010. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2010 Jun; 59(21):657-61. PubMed ID: 20520590 [TBL] [Abstract][Full Text] [Related]
15. Risk of Guillain-Barré syndrome after exposure to pandemic influenza A(H1N1)pdm09 vaccination or infection: a Norwegian population-based cohort study. Ghaderi S; Gunnes N; Bakken IJ; Magnus P; Trogstad L; Håberg SE Eur J Epidemiol; 2016 Jan; 31(1):67-72. PubMed ID: 26008750 [TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome following receipt of influenza A (H1N1) 2009 monovalent vaccine in Korea with an emphasis on Brighton Collaboration case definition. Choe YJ; Cho H; Bae GR; Lee JK Vaccine; 2011 Mar; 29(11):2066-70. PubMed ID: 21255684 [TBL] [Abstract][Full Text] [Related]